Liquidia (LQDA) EBIT (2020 - 2026)
Liquidia (LQDA) posted EBIT of $85.5 million for Q2 2026, up 39.04% on a QoQ basis from $61.5 million in Q1 2026, and up 328.01% year-over-year from $20.0 million in Q2 2025.
Analysis
Liquidia (LQDA) EBIT (2020 - 2026) Analysis & Trends
Liquidia has reported EBIT for 7 years, with the latest figure at $85.5 million in Q2 2026.
- On a quarterly basis, EBIT rose 328.01% year-over-year to $85.5 million in Q2 2026; TTM through Jun 2026 was $168.6 million, a 221.96% increase from a year earlier, with the FY2025 full-year figure at -$51.4 million, up 57.64% from the prior year.
- EBIT was $85.5 million for Q2 2026 at Liquidia, up from $61.5 million in the prior quarter.
- The five-year high for EBIT was $85.5 million in Q2 2026, with the low at -$37.5 million in Q2 2025.
- Average EBIT over 5 years is -$7.7 million, with a median of -$14.7 million recorded in 2022.
- The sharpest annual moves came in 2023 and 2026: EBIT plunged 306.9% in 2023, then surged 328.01% in 2026.
- Over 5 years, EBIT stood at -$6.5 million in 2022, then slumped by 306.9% to -$26.4 million in 2023, then plunged by 36.58% to -$36.1 million in 2024, then soared by 154.8% to $19.8 million in 2025, then soared by 332.19% to $85.5 million in 2026.
- The last three EBIT figures came in at $85.5 million (Q2 2026), $61.5 million (Q1 2026), and $19.8 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.04 Bn | 624.28 Bn | 17.26 Bn | 7.14 Bn |
| 2 | AbbVie | 440.25 Bn | 433.68 Bn | 12.70 Bn | 6.43 Bn |
| 3 | Merck | 365.65 Bn | 358.51 Bn | 12.21 Bn | -584.00 Mn |
| 4 | Novartis Ag | 266.64 Bn | 258.95 Bn | 11.24 Bn | 4.75 Bn |
| 5 | Pfizer | 159.03 Bn | 147.33 Bn | 10.94 Bn | 4.27 Bn |
| 6 | Sanofi | 52.43 Bn | 45.05 Bn | 10.79 Bn | 1.22 Bn |
| 7 | Revolution Medicines | 44.19 Bn | 44.19 Bn | - | -505.13 Mn |
| 8 | Incyte | 25.29 Bn | 20.75 Bn | 1.57 Bn | 697.90 Mn |
| 9 | United Therapeutics | 21.44 Bn | 18.77 Bn | 683.80 Mn | 330.80 Mn |
| 10 | Liquidia | 6.09 Bn | 5.81 Bn | 160.92 Mn | 85.52 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 85.52 Mn |
| Mar 31, 2026 | 61.50 Mn |
| Dec 31, 2025 | 19.79 Mn |
| Sep 30, 2025 | 1.77 Mn |
| Jun 30, 2025 | -37.51 Mn |
| Mar 31, 2025 | -35.43 Mn |
| Dec 31, 2024 | -36.11 Mn |
| Sep 30, 2024 | -29.19 Mn |
| Jun 30, 2024 | -27.20 Mn |
| Mar 31, 2024 | -28.80 Mn |
| Dec 31, 2023 | -26.44 Mn |
| Sep 30, 2023 | -14.89 Mn |
| Jun 30, 2023 | -22.83 Mn |
| Mar 31, 2023 | -9.23 Mn |
| Dec 31, 2022 | -6.50 Mn |
| Sep 30, 2022 | -8.83 Mn |
| Jun 30, 2022 | -8.97 Mn |
| Mar 31, 2022 | -14.47 Mn |
| Dec 31, 2021 | -11.36 Mn |
| Sep 30, 2021 | -7.08 Mn |